ストックスクリーナーアプリを入手
22.22
0.09%
-0.02
前日終値:
$22.24
開ける：
$22.26
24時間の取引高:
130.41K
Relative Volume:
0.70
時価総額：
$1.43B
収益：
-
当期純損益:
$-143.59M
株価収益率:
-7.8694
EPS:
-2.8236
ネットキャッシュフロー:
$-119.47M
1週間 パフォーマンス:
-3.35%
1か月 パフォーマンス:
-10.94%
6か月 パフォーマンス:
+20.24%
1年 パフォーマンス:
-10.66%
1日の値動き範囲:
$21.76
$22.40
1週間の範囲:
$21.76
$23.64
52週間の値動き範囲:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
PHVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
22.22 | 1.43B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-15 | 開始されました | H.C. Wainwright | Buy |
| 2025-10-09 | アップグレード | BofA Securities | Underperform → Neutral |
| 2025-06-11 | 開始されました | Guggenheim | Buy |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-09-25 | 開始されました | Wedbush | Outperform |
| 2023-08-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | 開始されました | Bryan Garnier | Buy |
| 2022-09-13 | 再開されました | JMP Securities | Mkt Outperform |
| 2022-08-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-05-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-03-02 | 開始されました | BofA Securities | Neutral |
| 2021-03-02 | 開始されました | Morgan Stanley | Overweight |
| 2021-03-02 | 開始されました | Oppenheimer | Outperform |
| 2021-03-02 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Pharvaris Nv (PHVS) 最新ニュース
How sentiment analysis helps forecast Pharvaris N.V.2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
What recovery options are there for Pharvaris N.V.Market Trend Review & Growth Focused Stock Reports - newser.com
Is Pharvaris N.V. (9EN) stock undervalued after correctionJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
Will Pharvaris N.V. stock attract ESG investorsJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com
Is Pharvaris N.V. stock safe for conservative investorsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Can Pharvaris N.V. (9EN) stock reach $200 price targetWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
Can Pharvaris N.V. stock deliver sustainable ROEJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Technical signs of recovery in Pharvaris N.V.CPI Data & Fast Gaining Stock Strategy Reports - newser.com
Can Pharvaris N.V. (9EN) stock deliver strong annual returnsM&A Rumor & Fast Exit Strategy with Risk Control - newser.com
How forex fluctuations impact Pharvaris N.V. (9EN) stockBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Visual analytics tools that track Pharvaris N.V. performance2025 Macro Impact & Daily Volume Surge Signals - newser.com
How Pharvaris N.V. stock compares to market leaders2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Full technical analysis of Pharvaris N.V. stockLong Setup & Weekly Setup with ROI Potential - newser.com
Will earnings trigger a reversal in Pharvaris N.V.Insider Selling & Low Risk High Win Rate Stock Picks - newser.com
Institutional Investors May Adopt Severe Steps After Pharvaris N.V.'s (NASDAQ:PHVS) Latest 3.4% Drop Adds to a Year Losses - 富途牛牛
How interest rate cuts could boost Pharvaris N.V. stockJuly 2025 Highlights & High Accuracy Investment Signals - fcp.pa.gov.br
How Pharvaris N.V. (9EN) stock trades in high volatility2025 Macro Impact & AI Enhanced Trading Alerts - newser.com
Why Pharvaris N.V. stock is favored by pension fundsTrade Exit Report & Precise Swing Trade Alerts - fcp.pa.gov.br
Pharvaris Nv (PHVS) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):